Inscrição YC de 20n
20n passou pela Y Combinator no batch Winter 2015 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.
- Batch YC
- Winter 2015
- Indústria
- HealthcareIndustrial Bio
- Tamanho da equipe
- 2
- Status
- Inactive
- Lançada
- 2014
Fundadores
Saurabh SrivastavaFounder/CEO
Chris AndersonFounder/CSO
O que 20n faz
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that predict DNA design for novel industrial biotech and health applications. At 20n, we are taking a fresh look at turning biological data into information. We approach it as a big data learning problem, and bring to bear techniques from machine learning, distributed systems, AI planning, program synthesis, data mining, and natural language processing. With the support of DARPA [2], we are building a team of computer scientists, and bioengineers to look at biology in fundamentally new ways. Our current customers include industrial biotech firms that are leading the charge in transitioning us from traditional unsustainable means of manufacturing to sustainable biological processes leading to advanced fuels, materials, therapeutics, and flavors and fragrances. 20n’s technology helps them enter markets previously thought inaccessible for biology. [1] Sequencing DNA costs $4k/genome ( and is expected to go down to $1k/genome. Synthesizing DNA is at 20cents/bp, and is expected to go down to 0.1cents/bp. [2] DARPA in the past supported work that led to the internet, stealth planes, GPS, and even Douglas Engelbart’s mother-of-all-demos.
Inscrição YC de 20n, reconstruída
Inscrição Y Combinator
20n, lote Winter 2015. As verdadeiras perguntas do formulário, respondidas com dados públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
20n
Using AI to predict biochemistry for manufacturing
We are building computational systems that use AI and machine learning to predict DNA designs for industrial biotech and therapeutics. Our product helps industrial biotech firms design biological systems that can produce fuels, materials, flavors, and medicines that were previously inaccessible by traditional methods.
We live in San Francisco, CA, and would base the company here after YC.
San Francisco has the technical talent and biotech ecosystem we need to grow. It keeps us close to early industrial biotech customers and partners.
21 respostas a mais na inscrição completa
Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.
Perguntas Frequentes
Esta é a inscrição real da YC de 20n?
Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de 20n (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como 20n se apresentaria à YC, não o texto que eles submeteram.
Em qual batch da YC 20n esteve?
20n fez parte do batch Winter 2015 da Y Combinator.
Quem fundou o 20n?
O 20n foi fundado por Saurabh Srivastava, Chris Anderson.
O que o 20n faz?
Using AI to predict biochemistry for manufacturing and therapeutics
Como eu leio o application completo reconstruído?
Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do 20n, e de todos os outros lotes do YC, está no YC Insights.
Mais startups YC como 20n
